Invention Grant
- Patent Title: Bicyclic bromodomain inhibitors
-
Application No.: US15486256Application Date: 2017-04-12
-
Publication No.: US10010556B2Publication Date: 2018-07-03
- Inventor: John Frederick Quinn , Bryan Cordell Duffy , Shuang Liu , Ruifang Wang , May Xiaowu Jiang , Gregory Scott Martin , Gregory Steven Wagner , Peter Ronald Young
- Applicant: ZENITH EPIGENETICS LTD.
- Applicant Address: CA Calgary, AB
- Assignee: Zenith Epigenetics Ltd.
- Current Assignee: Zenith Epigenetics Ltd.
- Current Assignee Address: CA Calgary, AB
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/52 ; A61K31/437 ; A61K31/423 ; A61K31/422 ; A61K31/498 ; A61K31/517 ; A61K31/4985 ; A61K31/496 ; A61K31/4184 ; A61K31/4545 ; A61K45/06
Abstract:
The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
Public/Granted literature
- US20170216301A1 NOVEL BICYCLIC BROMODOMAIN INHIBITORS Public/Granted day:2017-08-03
Information query
IPC分类:
